Trial
NCT02512692
Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical University of South Carolina
Collaborators
—
Condition
Intrahepatic Cholangiocarcinoma
Intervention
SIR-Spheres microspheres (Yttrium-90 Microspheres)
Why stopped
Enrollment closed by internal scientific review committee due to slow accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-18